• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cardiac device implantations in obese patients: Success rates and complications.肥胖患者的心脏设备植入:成功率与并发症
Clin Cardiol. 2017 Apr;40(4):230-234. doi: 10.1002/clc.22650. Epub 2017 Mar 23.
2
Comparison of ICD implantation in obese and nonobese patients.肥胖患者与非肥胖患者植入式心律转复除颤器植入情况的比较。
Pacing Clin Electrophysiol. 2014 Apr;37(4):481-5. doi: 10.1111/pace.12297. Epub 2013 Nov 11.
3
Safety and efficacy of applying a low-dose radiation fluoroscopy protocol in device implantations.应用低剂量辐射透视协议在器械植入中的安全性和有效性。
Europace. 2017 Aug 1;19(8):1364-1368. doi: 10.1093/europace/euw189.
4
Prevalence, Outcomes, and Costs According to Patient Frailty Status for 2.9 Million Cardiac Electronic Device Implantations in the United States.美国 290 万例心脏电子设备植入患者的患病率、结局和费用与患者脆弱状态的关系。
Can J Cardiol. 2019 Nov;35(11):1465-1474. doi: 10.1016/j.cjca.2019.07.632. Epub 2019 Aug 8.
5
The effect of an ultra-low frame rate and antiscatter grid-less radiation protocol for cardiac device implantations.超低帧率和无防散射格栅辐射方案对心脏设备植入的影响。
Pacing Clin Electrophysiol. 2017 Dec;40(12):1380-1383. doi: 10.1111/pace.13229. Epub 2017 Nov 28.
6
Mortality After Magnetic Resonance Imaging of the Brain in Patients With Cardiovascular Implantable Devices.心脏植入电子设备患者的脑部磁共振成像后的死亡率。
Circ Arrhythm Electrophysiol. 2018 Jan;11(1):e005480. doi: 10.1161/CIRCEP.117.005480.
7
Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.瑞典植入式电子设备的使用现状:来自瑞典起搏器和植入式心脏复律除颤器注册中心的数据。
Europace. 2015 Jan;17(1):69-77. doi: 10.1093/europace/euu233. Epub 2014 Oct 21.
8
Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure.体重指数与心力衰竭老年患者心脏再同步化治疗与植入式心脏复律除颤器治疗的结局。
Eur J Heart Fail. 2019 Sep;21(9):1093-1102. doi: 10.1002/ejhf.1552. Epub 2019 Jul 29.
9
The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.用于心脏植入式电子设备(CIED)手术的消毒皮肤准备剂的改变对感染风险的影响。
Pacing Clin Electrophysiol. 2015 Feb;38(2):240-6. doi: 10.1111/pace.12514. Epub 2014 Sep 16.
10
Outcomes after elective abdominal aortic aneurysm repair in obese versus nonobese patients.肥胖与非肥胖患者择期腹主动脉瘤修复术后的结果。
J Vasc Surg. 2018 Dec;68(6):1696-1705. doi: 10.1016/j.jvs.2018.03.414. Epub 2018 Jun 7.

引用本文的文献

1
Treatment options for heart failure in individuals with overweight or obesity: a review.超重或肥胖个体心力衰竭的治疗选择:一项综述
Future Cardiol. 2025 Apr;21(5):315-329. doi: 10.1080/14796678.2025.2479378. Epub 2025 Mar 18.
2
Impact of body mass index on in-hospital outcomes in patients receiving leadless pacemakers: A five-category analysis.体重指数对接受无导线起搏器患者住院结局的影响:一项五类分析。
Heart Rhythm O2. 2024 Oct 1;5(12):883-889. doi: 10.1016/j.hroo.2024.09.017. eCollection 2024 Dec.
3
Obesity paradox in patients with reduced ejection fraction eligible for device implantation - an observational study.射血分数降低且适合植入装置的患者中的肥胖悖论——一项观察性研究
ESC Heart Fail. 2024 Dec;11(6):3616-3625. doi: 10.1002/ehf2.14961. Epub 2024 Jul 19.
4
Zero to minimal fluoroscopy for cardiac electronic device implantation: A systematic review and meta-analysis.心脏电子设备植入术中零至最小透视:一项系统评价和荟萃分析。
J Arrhythm. 2023 Nov 15;40(1):38-46. doi: 10.1002/joa3.12949. eCollection 2024 Feb.
5
Trends in Cardiovascular Implantable Electronic Device Insertion Between 1988 and 2018 in Olmsted County.1988年至2018年奥尔姆斯特德县心血管植入式电子设备植入趋势
JACC Clin Electrophysiol. 2022 Jan;8(1):88-100. doi: 10.1016/j.jacep.2021.06.006. Epub 2021 Aug 25.
6
Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry.体重指数与心脏再同步治疗意图和左心室导线植入失败的相关性:来自 NCDR 植入式心脏复律除颤器登记处的见解。
J Interv Card Electrophysiol. 2020 Mar;57(2):279-288. doi: 10.1007/s10840-019-00550-x. Epub 2019 Apr 19.

本文引用的文献

1
Safety and efficacy of applying a low-dose radiation fluoroscopy protocol in device implantations.应用低剂量辐射透视协议在器械植入中的安全性和有效性。
Europace. 2017 Aug 1;19(8):1364-1368. doi: 10.1093/europace/euw189.
2
Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity.持续肥胖对心房的电生理、电解剖和结构重塑的影响。
J Am Coll Cardiol. 2015 Jul 7;66(1):1-11. doi: 10.1016/j.jacc.2015.04.058.
3
Prospective study to develop surface landmarks for blind axillary vein puncture for permanent pacemaker and defibrillator lead implantation and compare it to available contrast venography guided technique.前瞻性研究旨在为永久性起搏器和除颤器导线植入的盲穿腋静脉开发体表标志,并将其与现有的造影剂静脉造影引导技术进行比较。
Indian Heart J. 2015 Mar-Apr;67(2):136-40. doi: 10.1016/j.ihj.2015.04.007. Epub 2015 May 13.
4
Peri-operative management of the obese surgical patient 2015: Association of Anaesthetists of Great Britain and Ireland Society for Obesity and Bariatric Anaesthesia.2015 年肥胖手术患者的围手术期管理:英国和爱尔兰麻醉师协会肥胖与减重麻醉学会。
Anaesthesia. 2015 Jul;70(7):859-76. doi: 10.1111/anae.13101. Epub 2015 May 7.
5
Pneumothorax as a complication of central venous catheter insertion.气胸作为中心静脉导管插入术的并发症。
Ann Transl Med. 2015 Mar;3(3):40. doi: 10.3978/j.issn.2305-5839.2015.02.11.
6
Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.心脏植入式电子设备植入后的并发症:丹麦全国完整队列分析
Eur Heart J. 2014 May;35(18):1186-94. doi: 10.1093/eurheartj/eht511. Epub 2013 Dec 17.
7
Comparison of ICD implantation in obese and nonobese patients.肥胖患者与非肥胖患者植入式心律转复除颤器植入情况的比较。
Pacing Clin Electrophysiol. 2014 Apr;37(4):481-5. doi: 10.1111/pace.12297. Epub 2013 Nov 11.
8
Obesity begets atrial fibrillation: a contemporary summary.肥胖引发心房颤动:当代综述。
Circulation. 2013 Jul 23;128(4):401-5. doi: 10.1161/CIRCULATIONAHA.113.001840.
9
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).2013年欧洲心脏病学会(ESC)心脏起搏与心脏再同步治疗指南:欧洲心脏病学会(ESC)心脏起搏与再同步治疗特别工作组。与欧洲心律协会(EHRA)合作制定。
Eur Heart J. 2013 Aug;34(29):2281-329. doi: 10.1093/eurheartj/eht150. Epub 2013 Jun 24.
10
Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry.低体重指数而非肥胖与植入式心脏复律除颤器受者的院内不良事件和死亡率相关:来自全国心血管数据注册中心的见解。
J Am Heart Assoc. 2012 Dec;1(6):e003863. doi: 10.1161/JAHA.112.003863. Epub 2012 Dec 19.

肥胖患者的心脏设备植入:成功率与并发症

Cardiac device implantations in obese patients: Success rates and complications.

作者信息

Attanasio Philipp, Lacour Philipp, Ernert Andrea, Pieske Burkert, Haverkamp Wilhelm, Blaschke Florian, Dalle Vedove Francesco, Huemer Martin

机构信息

Department of Cardiology, Campus Virchow-Klinikum, Charité University Hospital Berlin, Germany.

Department of Biometrics and Clinical Epidemiology, Campus Virchow-Klinikum, Charité University Hospital Berlin, Germany.

出版信息

Clin Cardiol. 2017 Apr;40(4):230-234. doi: 10.1002/clc.22650. Epub 2017 Mar 23.

DOI:10.1002/clc.22650
PMID:28333397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6490533/
Abstract

BACKGROUND

Obesity is associated with increased complications and potentially worse outcomes for various cardiac interventions. This study analyzed the success rate and complication rates associated with implantation of cardiac implantable electronic devices (CIEDs) in obese patients.

HYPOTHESIS

Success rates are lower and complication rates higher in obese patients.

METHODS

Consecutive patients undergoing CIED implantation between 2011 and 2015 in our hospital were included. Patients were categorized into obese and nonobese groups according to body mass index (BMI); cutoff was 30 kg/m . Patient characteristics, complication rates, procedural duration, and fluoroscopy data were compared between the 2 groups.

RESULTS

A total of 965 patients (mean age, 69.0 ± 12.9 years; 67% male) were included. Of these, 249 (25.8%) patients were classified obese and 716 (74.2%) nonobese. Mean BMI was 34.7 ± 4.7 kg/m vs 25.1 ± 3.0 kg/m , respectively. There was no difference in procedural success rates between the 2 groups (97.2% vs 97.1%, respectively). Major complications were significantly lower in the obese group compared with the nonobese group (11 [4.4%] vs 62 [8.7%]; P < 0.05). Procedural duration and fluoroscopy duration were not different between the 2 groups, but the total dose-area product was significantly higher in obese patients vs nonobese patients (4012 ± 5416 cGcm vs 2692 ± 5277 cGcm ; P < 0.005).

CONCLUSIONS

CIED implantation can be safely and effectively achieved in patients with BMI >30 kg/m . However, total radiation dose was significantly higher in the obese group, emphasizing that efforts should be made to reduce radiation exposure in these patients.

摘要

背景

肥胖与各种心脏介入治疗的并发症增加以及潜在的更差预后相关。本研究分析了肥胖患者植入心脏植入式电子设备(CIED)的成功率和并发症发生率。

假设

肥胖患者的成功率较低,并发症发生率较高。

方法

纳入2011年至2015年在我院连续接受CIED植入的患者。根据体重指数(BMI)将患者分为肥胖组和非肥胖组;临界值为30kg/m²。比较两组患者的特征、并发症发生率、手术持续时间和透视数据。

结果

共纳入965例患者(平均年龄69.0±12.9岁;67%为男性)。其中,249例(25.8%)患者被分类为肥胖,716例(74.2%)为非肥胖。平均BMI分别为34.7±4.7kg/m²和25.1±3.0kg/m²。两组手术成功率无差异(分别为97.2%和97.1%)。肥胖组的主要并发症明显低于非肥胖组(11例[4.4%]对62例[8.7%];P<0.05)。两组手术持续时间和透视持续时间无差异,但肥胖患者的总剂量面积乘积显著高于非肥胖患者(4012±5416cGcm²对2692±5277cGcm²;P<0.005)。

结论

BMI>30kg/m²的患者可以安全有效地进行CIED植入。然而,肥胖组的总辐射剂量明显更高,强调应努力减少这些患者的辐射暴露。